Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1992-10-22
1994-02-15
Hollinden, Gary
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
540145, 514184, 514410, 436172, 436800, A61B 500, A61K 31555, A61K 3140, C07B 4700
Patent
active
052864740
ABSTRACT:
A process of tumor identification comprising administering a carotenoporphyrin to a tumor-bearing mammalian host and irradiating the mammalian host with light whereupon the carotenoporphyrin, which has been preferentially taken up by the tumor tissue, fluoresces and permits precise identification of the location, size and shape of the tumor tissue. An improved process of synthesizing carotenoporphyrins 1-5 is also provided.
REFERENCES:
patent: 4806488 (1989-02-01), Berger et al.
patent: 5015463 (1991-05-01), Dougherty et al.
patent: 5149708 (1992-09-01), Dolphin et al.
Land, E. J. et al. J. Phys. Chem. 91(18):4831-4835 (1987).
Gust, Jr. John D.
Jori Giulio
Moore Ana L.
Moore Thomas A.
Reddi Elena
Arizona Board of Regents, a body corporate, acting for and on be
Hollinden Gary
Mybeck Richard R.
LandOfFree
Use of carotenoporphyrins as tumor localizing agents for diagnos does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of carotenoporphyrins as tumor localizing agents for diagnos, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of carotenoporphyrins as tumor localizing agents for diagnos will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1204950